| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 | Ophthalmology | 2014 | 4,878 |
| 2 | Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050 | Ophthalmology | 2016 | 2,988 |
| 3 | Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales | Ophthalmology | 2003 | 2,779 |
| 4 | Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House Classification | Ophthalmology | 1991 | 2,238 |
| 5 | Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration | Ophthalmology | 2012 | 2,021 |
| 6 | Prevalence of Age-related Maculopathy | Ophthalmology | 1992 | 1,712 |
| 7 | Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration | Ophthalmology | 2012 | 1,585 |
| 8 | Ranibizumab for Diabetic Macular Edema | Ophthalmology | 2012 | 1,426 |
| 9 | Early Photocoagulation for Diabetic Retinopathy | Ophthalmology | 1991 | 1,344 |
| 10 | Clinical Classification of Age-related Macular Degeneration | Ophthalmology | 2013 | 1,308 |
| 11 | Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema | Ophthalmology | 2010 | 1,303 |
| 12 | Imaging of Macular Diseases with Optical Coherence Tomography | Ophthalmology | 1995 | 1,235 |
| 13 | The RESTORE Study | Ophthalmology | 2011 | 1,230 |
| 14 | Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study | Ophthalmology | 2009 | 1,204 |
| 15 | Predictors of Long-term Progression in the Early Manifest Glaucoma Trial | Ophthalmology | 2007 | 1,202 |
| 16 | Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration | Ophthalmology | 2006 | 1,155 |
| 17 | Photocoagulation Treatment of Proliferative Diabetic Retinopathy | Ophthalmology | 1981 | 1,114 |
| 18 | Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study11The authors have no proprietary interest in the equipment and techniques described in this article. | Ophthalmology | 1999 | 1,092 |
| 19 | Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery | Ophthalmology | 2001 | 1,083 |
| 20 | The Wisconsin Age-related Maculopathy Grading System | Ophthalmology | 1991 | 1,078 |
| 21 | Prevalence of Age-related Maculopathy in Australia | Ophthalmology | 1995 | 1,000 |
| 22 | Uveal Melanoma: Trends in Incidence, Treatment, and Survival | Ophthalmology | 2011 | 999 |
| 23 | Limbal Autograft Transplantation for Ocular Surface Disorders | Ophthalmology | 1989 | 996 |
| 24 | Survey of 1264 patients with orbital tumors and simulating lesions | Ophthalmology | 2004 | 995 |
| 25 | Intravitreal triamcinolone for refractory diabetic macular edema | Ophthalmology | 2002 | 993 |
| 26 | Outdoor Activity Reduces the Prevalence of Myopia in Children | Ophthalmology | 2008 | 980 |
| 27 | Survey of 520 Eyes with Uveal Metastases | Ophthalmology | 1997 | 975 |
| 28 | Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion | Ophthalmology | 2010 | 950 |
| 29 | Risk factors for age-related macular degeneration | Ophthalmology | 2001 | 942 |
| 30 | Automated Identification of Diabetic Retinopathy Using Deep Learning | Ophthalmology | 2017 | 936 |
| 31 | Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema | Ophthalmology | 2014 | 930 |
| 32 | Ranibizumab for Macular Edema following Central Retinal Vein Occlusion | Ophthalmology | 2010 | 924 |
| 33 | Prevalence of Glaucoma | Ophthalmology | 1992 | 903 |
| 34 | The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole | Ophthalmology | 2013 | 900 |
| 35 | Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision) | Ophthalmology | 2016 | 896 |
| 36 | The Five-year Incidence and Progression of Age-related Maculopathy | Ophthalmology | 1997 | 894 |
| 37 | The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia | Ophthalmology | 2010 | 889 |
| 38 | Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON | Ophthalmology | 2013 | 887 |
| 39 | Prevalence of Open-angle Glaucoma in Australia | Ophthalmology | 1996 | 873 |
| 40 | Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045 | Ophthalmology | 2021 | 867 |
| 41 | The relationship between glaucoma and myopia | Ophthalmology | 1999 | 841 |
| 42 | Fundus Photographic Risk Factors for Progression of Diabetic Retinopathy | Ophthalmology | 1991 | 834 |
| 43 | Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease11Reprint requests to: Linda Lewis, 575 Anton Blvd, Suite 900, Costa Mesa, CA 92626. | Ophthalmology | 2000 | 808 |
| 44 | Risk factors associated with age-related macular degeneration | Ophthalmology | 2000 | 803 |
| 45 | Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery | Ophthalmology | 1980 | 802 |
| 46 | Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion | Ophthalmology | 2010 | 789 |
| 47 | Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema | Ophthalmology | 2016 | 764 |
| 48 | Visual Acuity and the Causes of Visual Loss in Australia | Ophthalmology | 1996 | 761 |
| 49 | Incidence and prevalence of uveitis in Northern California The Northern California Epidemiology of Uveitis Study | Ophthalmology | 2004 | 742 |
| 50 | The Wisconsin Epidemiologic Study of Diabetic Retinopathy | Ophthalmology | 1984 | 740 |
